Snyder Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-311,008
| Closed | -$3.84M | – | 69 |
|
|
2024
Q4 | $3.84M | Sell |
311,008
-1,569,609
| -83% | -$18M | 0.08% | 69 |
|
|
2024
Q3 | $21.4M | Sell |
1,880,617
-111,229
| -6% | -$1.12M | 0.44% | 63 |
|
|
2024
Q2 | $14.2M | Sell |
1,991,846
-189,812
| -9% | -$1.45M | 0.32% | 63 |
|
|
2024
Q1 | $14.6M | Buy |
2,181,658
+119,630
| +6% | +$823K | 0.31% | 63 |
|
|
2023
Q4 | $14.5M | Sell |
2,062,028
-168,903
| -8% | -$1.09M | 0.33% | 66 |
|
|
2023
Q3 | $21.1M | Buy |
2,230,931
+76,551
| +4% | +$921K | 0.48% | 64 |
|
|
2023
Q2 | $30.1M | Buy |
2,154,380
+425,092
| +25% | +$7.25M | 0.64% | 54 |
|
|
2023
Q1 | $32.4M | Sell |
1,729,288
-240,153
| -12% | -$3.94M | 0.69% | 56 |
|
|
2022
Q4 | $27.1M | Sell |
1,969,441
-7,119
| -0.4% | -$109K | 0.61% | 60 |
|
|
2022
Q3 | $37.8M | Buy |
1,976,560
+345,389
| +21% | +$6.29M | 0.97% | 38 |
|
|
2022
Q2 | $24.9M | Sell |
1,631,171
-24,300
| -1% | -$359K | 0.67% | 58 |
|
|
2022
Q1 | $33.7M | Sell |
1,655,471
-39,924
| -2% | -$813K | 0.86% | 41 |
|
|
2021
Q4 | $49.5M | Sell |
1,695,395
-85,540
| -5% | -$2.45M | 1.19% | 31 |
|
|
2021
Q3 | $38.4M | Sell |
1,780,935
-16,584
| -0.9% | -$400K | 1.02% | 37 |
|
|
2021
Q2 | $46.1M | Sell |
1,797,519
-392,449
| -18% | -$8.38M | 1.29% | 27 |
|
|
2021
Q1 | $39.9M | Sell |
2,189,968
-317,988
| -13% | -$5.28M | 1.15% | 31 |
|
|
2020
Q4 | $28.9M | Buy |
2,507,956
+205,335
| +9% | +$1.88M | 0.95% | 41 |
|
|
2020
Q3 | $17.5M | Sell |
2,302,621
-2,258
| -0.1% | -$17.1K | 0.75% | 47 |
|
|
2020
Q2 | $15.1M | Buy |
2,304,879
+23,974
| +1% | +$134K | 0.69% | 49 |
|
|
2020
Q1 | $11.7M | Buy |
2,280,905
+98,519
| +5% | +$596K | 0.66% | 50 |
|
|
2019
Q4 | $16.7M | Sell |
2,182,386
-69,667
| -3% | -$406K | 0.66% | 52 |
|
|
2019
Q3 | $11.9M | Buy |
2,252,053
+9,761
| +0.4% | +$60.6K | 0.52% | 55 |
|
|
2019
Q2 | $12.6M | Sell |
2,242,292
-111,525
| -5% | -$460K | 0.56% | 53 |
|
|
2019
Q1 | $10M | Buy |
2,353,817
+261,344
| +12% | +$1.07M | 0.47% | 57 |
|
|
2018
Q4 | $8.58M | Buy |
2,092,473
+195,595
| +10% | +$1.02M | 0.46% | 55 |
|
|
2018
Q3 | $13M | Buy |
+1,896,878
| New | +$11.2M | 0.58% | 51 |
|
Other funds holding CDMO
Snyder Capital Management's CDMO Position: Q1 2025 in Review
Snyder Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 311,008 shares — an estimated $3.84M sold.
Snyder Capital Management first reported a position in CDMO in Q3 2018 and held it in 26 quarters. The position peaked at $49.5M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Snyder Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Snyder Capital Management sold 311,008 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $3.84M.
- Snyder Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 26 quarters.
- Snyder Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $49.5M in Q4 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Snyder Capital Management's 13F filing for Q1 2025, filed 15 May 2025.